541 related articles for article (PubMed ID: 17551985)
1. Sickle cell disease caused by Hb S/Québec-CHORI: treatment with hydroxyurea and response.
Tubman VN; Bennett CM; Luo HY; Chui DH; Heeney MM
Pediatr Blood Cancer; 2007 Aug; 49(2):207-10. PubMed ID: 17551985
[TBL] [Abstract][Full Text] [Related]
2. Strategy for identification by mass spectrometry of a new human hemoglobin variant with two mutations in Cis in the beta-globin chain: Hb S-Clichy [beta6(A3)Glu-->Val; beta8(A5)Lys-->Thr].
Zanella-Cleon I; Préhu C; Joly P; Riou J; Becchi M; Wajcman H; Francina A
Hemoglobin; 2009; 33(3):177-87. PubMed ID: 19657831
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell disease due to compound heterozygosity for Hb S and a novel 7.7-kb beta-globin gene deletion.
Andersson BA; Wering ME; Luo HY; Basran RK; Steinberg MH; Smith HP; Chui DH
Eur J Haematol; 2007 Jan; 78(1):82-5. PubMed ID: 17038017
[TBL] [Abstract][Full Text] [Related]
4. A rare case of a compound heterozygote hemoglobin S/hemoglobin Fannin-Lubbock-I individual. Is it a sickling disorder?
Burns NK; Risin SA
Lab Hematol; 2010 Jun; 16(2):26-7. PubMed ID: 20534428
[No Abstract] [Full Text] [Related]
5. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
[TBL] [Abstract][Full Text] [Related]
6. Unusual sickle cell disease observed for the first time in Italy: Hb S-Hb D Los Angeles.
Samperi P; Dibenedetto SP; di Cataldo A; Mancuso GR; Schilirò G
Haematologica; 1990; 75(5):464-6. PubMed ID: 2097263
[TBL] [Abstract][Full Text] [Related]
7. Molecular exclusion of haemoglobin SD disease by prenatal diagnosis.
Fodor FH; Eng CM
Prenat Diagn; 1999 Jan; 19(1):58-60. PubMed ID: 10073909
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobinopathies mimicking Hb S/beta-thalassemia: Hb S/S with alpha-thalassemia and Hb S/Volga.
Luo HY; Heeney M; Wang WC; Eung SH; Ware RE; Steinberg MH; Chui DH
Am J Hematol; 2006 May; 81(5):361-5. PubMed ID: 16628724
[TBL] [Abstract][Full Text] [Related]
9. A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: phenotype and molecular characteristics.
Kutlar F; Redding-Lallinger R; Meiler SE; Bakanay SM; Borders L; Kutlar A
Acta Haematol; 2010; 124(2):120-4. PubMed ID: 20861612
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patients.
Koenig SC; Becirevic E; Hellberg MS; Li MY; So JC; Hankins JS; Ware RE; McMahon L; Steinberg MH; Luo HY; Chui DH
Am J Hematol; 2009 Sep; 84(9):603-6. PubMed ID: 19650141
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin S/Hemoglobin Quebec-Chori Presenting as Sickle Cell Disease: A Case Report.
Goode E; Boruchov D; Oliveira JL; Lau CC
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e775-e777. PubMed ID: 32657857
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori.
Witkowska HE; Lubin BH; Beuzard Y; Baruchel S; Esseltine DW; Vichinsky EP; Kleman KM; Bardakdjian-Michau J; Pinkoski L; Cahn S
N Engl J Med; 1991 Oct; 325(16):1150-4. PubMed ID: 1891024
[No Abstract] [Full Text] [Related]
14. [Hemoglobinopathy S with an interaction of HbS and Hb G-Ferrara].
Cañizares ME; Martínez G; Hernández S; Raymond P; Colombo B
Sangre (Barc); 1983; 28(6):770-4. PubMed ID: 6673168
[No Abstract] [Full Text] [Related]
15. A novel sickle hemoglobin: hemoglobin S-south end.
Luo HY; Adewoye AH; Eung SH; Skelton TP; Quillen K; McMahon L; Steinberg MH; Chui DH
J Pediatr Hematol Oncol; 2004 Nov; 26(11):773-6. PubMed ID: 15543018
[TBL] [Abstract][Full Text] [Related]
16. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
17. Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients.
Adekile AD
Hemoglobin; 2011; 35(5-6):607-17. PubMed ID: 21999156
[TBL] [Abstract][Full Text] [Related]
18. Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.
Akinbami AO; Campbell AD; Han ZJ; Luo HY; Chui DH; Steinberg MH
Hemoglobin; 2016; 40(1):64-5. PubMed ID: 26372199
[TBL] [Abstract][Full Text] [Related]
19. Association of HbS and a new low oxygen affinity variant, Hb Canebière, [beta102(G4)Asn->Lys] in a healthy child.
Thuret I; Mely L; Kister J; Kiger L; Merono F; Badier M; Badens C
Haematologica; 2004 Sep; 89(9):ECR31. PubMed ID: 15377483
[No Abstract] [Full Text] [Related]
20. Inherited hemoglobin disorders in Guinea-Bissau, West Africa: a population study.
Masmas TN; Garly ML; Lisse IM; Rodriques A; Petersen PT; Birgens H
Hemoglobin; 2006; 30(3):355-64. PubMed ID: 16840226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
